×
App Icon
The Standard e-Paper
Read Offline Anywhere
★★★★ - on Play Store
Download Now

US regulator: No evidence yet linking weight-loss drugs to suicidal thoughts

Vocalize Pre-Player Loader

Audio By Vocalize

This image provided by Novo Nordisk in January 2023 shows packaging for the company's Wegovy drug. [AP Photo]

The U.S. Food and Drug Administration said on Thursday its preliminary review did not find evidence that weight-loss drugs such as Novo Nordisk's NOVOb.CO Wegovy were tied to suicidal thoughts and the agency will continue to study the issue.

Still, the FDA, which has listed suicidal thoughts as a potential safety signal for such drugs, said it could not definitively rule out that a small risk may exist due to the limited data available.

Get Full Access for Ksh299/Week.
Bold Reporting Takes Time, Courage and Investment. Stand With Us.
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in
Golf
Attyang, Kanjejo and Omore shine at February Nyanza Mug of the Month
Sports
Martial arts: Rising talents impress at inaugural Kisumu Chairman's Karate Open
Golf
Magical Kenya Open: Junior players inspired after battling world beaters in Karen
Sports
Beyond the playbook: Inside secrets of successful high school tacticians